High prevalence of antibiotic resistance and molecular characterization of integrons among shigella isolates in eastern china

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 3, 2013, Pages 1549-1551

  Shen, Yun ^a   Qian, Huimin ^a   Gong, Junjun ^a   Deng, Feifei ^a   Dong, Chen ^a   Zhou, Lu ^a   Guo, Hongxiong ^a  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFOTAXIME; COTRIMOXAZOLE; GENTAMICIN; NALIDIXIC ACID; NORFLOXACIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CHINA; HUMAN; INFANT; INTEGRON; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; FECES; FEMALE; HUMANS; INFANT; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; SHIGELLA FLEXNERI; SHIGELLA SONNEI;

EID: 84874032309     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02102-12     Document Type: Article

References (24)

1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM. 1999. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull. World Health Organ. 77:651- 666.
2. von Seidlein L, Kim DR, Ali M, Lee H, Wang X, Thiem VD, Canh do G, Chaicumpa W, Agtini MD, Hossain A, Bhutta ZA, Mason C, Sethabutr O, Talukder K, Nair GB, Deen JL, Kotloff K, Clemens J. 2006. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 3:e353. doi: 10.1371/journal.pmed.0030353.
3. Dai YC, Nie J, Zhang XF, Li ZF, Bai Y, Zeng ZR, Yu SY, Farkas T, Jiang X. 2004. Seroprevalence of antibodies against noroviruses among students in a Chinese military medical university. J. Clin. Microbiol. 42:4615- 4619.
4. Wang XY, Du L, Von Seidlein L, Xu ZY, Zhang YL, Hao ZY, Han OP, Ma JC, Lee HJ, Ali M, Han CQ, Xing ZC, Chen JC, Clemens J. 2005. Occurrence of Shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study. Am. J. Trop. Med. Hyg. 73:416-422.
5. Ye C, Lan R, Xia S, Zhang J, Sun Q, Zhang S, Jing H, Wang L, Li Z, Zhou Z, Zhao A, Cui Z, Cao J, Jin D, Huang L, Wang Y, Luo X, Bai X, Wang Y, Wang P, Xu Q, Xu J. 2010. Emergence of a new multidrug- resistant serotype X variant in an epidemic clone of Shigella flexneri. J. Clin. Microbiol. 48:419-426.
6. MoezArdalan K, Zali MR, Dallal MM, Hemami MR, Salmanzadeh- Ahrabi S. 2003. Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhea in Karaj Tehran, Iran. J. Health Popul. Nutr. 21:96 -102.
7. Wasfy MO, Oyofo BA, David JC, Ismail TF, el-Gendy AM, Mohran ZS, Sultan Y, Peruski LF Jr. 2000. Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. J. Health Popul. Nutr. 18:33-38.
8. Zhang R, Eggleston K, Rotimi V, Zeckhauser RJ. 2006. Antibiotic resistance as a global threat: evidence from China, Kuwait and the United States. Global Health 2:6. doi:10.1186/1744-8603-2-6.
9. Martinez-Freijo P, Fluit AC, Schmitz FJ, Verhoef J, Jones ME. 1999. Many class I integrons comprise distinct stable structures occurring in different species of enterobacteriaceae isolated from widespread geographic regions in Europe. Antimicrob. Agents Chemother. 43:686-689.
10. Ebner P, Garner K, Mathew A. 2004. Class 1 integrons in various Salmonella enterica serovars isolated from animals and identification of genomic island SGI1 in Salmonella enterica var. Meleagridis. J. Antimicrob. Chemother. 53:1004 -1009.
11. Krauland MG, Marsh JW, Paterson DL, Harrison LH. 2009. Integronmediated multidrug resistance in a global collection of nontyphoidal Salmonella enterica isolates. Emerg. Infect. Dis. 15:388 -396.
12. Ke X, Gu B, Pan S, Tong M. 2011. Epidemiology and molecular mechanism of integron-mediated antibiotic resistance in Shigella. Arch. Microbiol. 193:767-774.
13. Clinical and Laboratory Standards Institute. 2012. Methods for dilution and antimicrobial susceptibility tests for bacteria that grow aerobically, 9th ed. Approved standard M07-A9. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Dubois V, Parizano MP, Arpin C, Coulange L, Bezian MC, Quentin C. 2007. High genetic stability of integrons in clinical isolates of Shigella spp. of worldwide origin. Antimicrob. Agents Chemother. 51:1333-1340.
15. Vrints M, Mairiaux E, Van Meervenne E, Collard JM, Bertrand S. 2009. Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007. J. Clin. Microbiol. 47:1379 -1385.
16. Choi SY, Jeon YS, Lee JH, Choi B, Moon SH, von Seidlein L, Clemens JD, Dougan G, Wain J, Yu J, Lee JC, Seol SY, Lee BK, Song JH, Song M, Czerkinsky C, Chun J, Kim DW. 2007. Multilocus sequence typing analysis of Shigella flexneri isolates collected in Asian countries. J. Med. Microbiol. 56:1460 -1466.
17. Xia S, Xu B, Huang L, Zhao JY, Ran L, Zhang J, Chen H, Pulsrikarn C, Pornruangwong S, Aarestrup FM, Hendriksen RS. 2011. Prevalence and characterization of human Shigella infections in Henan Province, China, in 2006. J. Clin. Microbiol. 49:232-242.
18. Sivapalasingam S, Nelson JM, Joyce K, Hoekstra M, Angulo FJ, Mintz ED. 2006. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the national antimicrobial resistance monitoring system from 1999 to 2002. Antimicrob. Agents Chemother. 50:49 -54.
19. Folster JP, Pecic G, Bowen A, Rickert R, Carattoli A, Whichard JM. 2011. Decreased susceptibility to ciprofloxacin among Shigella isolates in the United States, 2006 to 2009. Antimicrob. Agents Chemother. 55: 1758-1760.
20. Moellering RC Jr. 2010. NDM-1-a cause for worldwide concern. N. Engl. J. Med. 363:2377-2379.
21. Syed-Abdul S, Jian WS, Lee P, Li YC, Hsu MH. 2011. Superbug demands organizational change of the healthcare system. J. Pharmacol. Pharmacother. 2:132-133.
22. Mukherjee S, Chakraborty R. 2007. Conjugation potential and class Iintegron carriage of resident plasmids in river water copiotrophs. Acta Microbiol. Immunol. Hung. 54:379 -397.
23. Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74:417- 433.
24. Boucher Y, Labbate M, Koenig JE, Stokes HW. 2007. Integrons: mobilizable platforms that promote genetic diversity in bacteria. Trends Microbiol. 15:301-309.